Dr. David Matthew Adelman, MD, PhD

Dr. Adelman practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Adelman's NPI, 1457541500, was assigned on July 25, 2007. Dr. Adelman graduated from Pritzker School of Medicine in 2003. Dr. Adelman holds Texas license N3417.

Dr. Adelman's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Adelman's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Texas Children's Hospital. Dmand AI also links Dr. Adelman to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adelman practices, 2 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Adelman's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Adelman is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Adelman's licenses on file in 11 states: Texas, Florida, Arizona, Oklahoma, Washington, Alabama, Georgia, Louisiana, Mississippi, Tennessee and New York.

Dmand AI lists breast reconstruction and breast surgery among the conditions Dr. Adelman treats.

CMS data shows 22 Medicare services from Dr. Adelman across 1 procedure code in 2024, all of them office visits, for 50 Medicare patients. Medicare paid $2,256 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 50 Medicare patients who saw Dr. Adelman in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Adelman's median patient age at 59, with 83% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Adelman for performance year 2024, reported as part of a group. Dr. Adelman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 24 procedures of mastectomy by Dr. Adelman, more than 82% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 43 papers to Dr. Adelman, published from 2001 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Plastic Surgery Procedures, Postoperative Complications and Surgical Flaps. Dr. Adelman has published most often in Plast Reconstr Surg. Dr. Adelman's most frequent co-authors are Matthew Mitsuru Hanasono, MD, Charles E. Butler, MD and Alexander F. Mericli, MD.

CMS Open Payments shows 593 general payments to Dr. Adelman from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. Integra LifeSciences Corporation paid the most, $714,726.

Dmand AI lists 1 award for Dr. Adelman.

Dr. Adelman graduated from Pritzker School of Medicine in 2003.

Dr. Adelman is in network with 3 carriers, including Aetna, Blue Cross Blue Shield of Michigan and CMS Medicare. HMO plans come from the most carriers, 2. Check the plan with the practice before a visit.